The shareholders can't blame management for this result. They have been very respectful of the situation and decided to take no remuneration until they find a new strategy or direction for the company. You don't see that often.
Ann: Results of Phase 2 Clinical Trial, page-15
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable